These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28242140)

  • 21. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric evaluation of MRI-guided multi-leaf collimator tracking and trailing for lung stereotactic body radiation therapy.
    Uijtewaal P; Borman PTS; Woodhead PL; Hackett SL; Raaymakers BW; Fast MF
    Med Phys; 2021 Apr; 48(4):1520-1532. PubMed ID: 33583042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
    Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
    Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of immobilization and performance status on intrafraction motion for stereotactic lung radiotherapy: analysis of 133 patients.
    Li W; Purdie TG; Taremi M; Fung S; Brade A; Cho BC; Hope A; Sun A; Jaffray DA; Bezjak A; Bissonnette JP
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1568-75. PubMed ID: 21075559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
    Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
    Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
    Rieber J; Abbassi-Senger N; Adebahr S; Andratschke N; Blanck O; Duma M; Eble MJ; Ernst I; Flentje M; Gerum S; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lohaus F; Lohr F; Petersen C; Schrade E; Streblow J; Uhlmann L; Wittig A; Sterzing F; Guckenberger M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):511-520. PubMed ID: 27843031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Setting up a lung stereotactic body radiotherapy service in a tertiary center in Eastern India: The process, quality assurance, and early experience.
    Shrimali RK; Saha A; Arun B; Prasath S; Nallathambi C; Bhoumik S; Mallick I; Achari RB; Chatterjee S
    J Cancer Res Ther; 2020; 16(4):888-899. PubMed ID: 32930136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of technology on the changing practice of lung SBRT.
    Aznar MC; Warren S; Hoogeman M; Josipovic M
    Phys Med; 2018 Mar; 47():129-138. PubMed ID: 29331227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
    Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
    Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the feasibility of cardiac substructure sparing in magnetic resonance imaging guided stereotactic lung radiotherapy.
    van der Pol LHG; Hackett SL; Hoesein FAAM; Snoeren LMW; Pomp J; Raaymakers BW; Verhoeff JJC; Fast MF
    Med Phys; 2023 Jan; 50(1):397-409. PubMed ID: 36210631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of field number and beam angle on ERE for lung stereotactic body radiotherapy with 1.5T MR-Linac.
    Ding S; Liu H; Wang B; Li Y; Li R; Liu B; Xia Y; Huang X
    Cancer Radiother; 2021 Jun; 25(4):366-372. PubMed ID: 33622638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.
    Rosen LR; Fischer-Valuck BW; Katz SR; Durci M; Wu HT; Syh J; Syh J; Patel B
    Tumori; 2014; 100(1):42-8. PubMed ID: 24675490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer.
    Merna C; Rwigema JC; Cao M; Wang PC; Kishan AU; Michailian A; Lamb J; Sheng K; Agazaryan N; Low DA; Kupelian P; Steinberg ML; Lee P
    Med Dosim; 2016; 41(1):87-91. PubMed ID: 26755076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
    Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forcing lateral electron disequilibrium to spare lung tissue: a novel technique for stereotactic body radiation therapy of lung cancer.
    Disher B; Hajdok G; Gaede S; Mulligan M; Battista JJ
    Phys Med Biol; 2013 Oct; 58(19):6641-62. PubMed ID: 24018569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of different treatment techniques and clinical factors over the intrafraction variation on lung stereotactic body radiotherapy.
    Rico M; Martínez E; Pellejero S; Bermejo B; Navarrete P; Barrado M; Campo M; Mañeru F; Villafranca E; Aristu J
    Clin Transl Oncol; 2016 Oct; 18(10):1011-8. PubMed ID: 26758718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stereotactic body radiotherapy. How to better protect normal tissues?].
    Pasquier D; Lacornerie T; Mirabel X; Brassart C; Vanquin L; Lartigau E
    Cancer Radiother; 2019 Oct; 23(6-7):630-635. PubMed ID: 31447339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inter- and intrafraction imaging during stereotactic body radiation therapy: Which solutions for which tumours?].
    Gensanne D; Hadj Henni A; Lauzin Y; Clarisse P; Thureau S
    Cancer Radiother; 2019 Dec; 23(8):891-895. PubMed ID: 31615729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compton scatter imaging: A promising modality for image guidance in lung stereotactic body radiation therapy.
    Redler G; Jones KC; Templeton A; Bernard D; Turian J; Chu JCH
    Med Phys; 2018 Mar; 45(3):1233-1240. PubMed ID: 29360151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.